ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Resident Blog - Edith Ford"
Episode Synopsis
PGY2 SOT Edith Ford joins us from Mayo Clinic in Phoenix, Arizona to discuss "A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection", which has recently received Breakthrough Therapy Designation for ABMR in kidney transplant recipients, as well as a quick discussion on antibody-mediated rejection and CD38 inhibitors.
More episodes of the podcast The mTOR You Know
Resident Blog - Brooke Aston
28/11/2025
A New Hope: Breaking Down Barriers for Patients Living with HIV on the Transplant Waitlist
25/11/2025
Mentorship Tips and Tricks - Webinar Audio
29/08/2025
The CMV Playbook - Part 2
15/07/2025
ISHLT 2025 Recap
25/06/2025
The CMV Playbook - Part 1
17/06/2025
Resident Blog - Marissa Maffei
05/06/2025
Resident Blog - Brittany Hunyh
05/06/2025
In God we trust